Re: COMPANY OF THE YEAR What's wrong w/this picture?

[Guest guest]

In a message dated 9/16/2005 4:38:04 PM Pacific Standard Time,

tigerpaw2c@... writes:

Sporanox, for fungal infections, generated 2004 sales of $655

million, an increase of 15.5% compared with 2003. In first-half

2005, sales for Sporanox were up 2% to $305 million, with a decrease

of 51.7% in U.S. markets.

Did you all read this? Sporonox sales are UP worldwide, even with a 51%

DECREASE in US markets.

Wake up people!!! We, in the US are being fed a bunch of useless steriods,

inhalers and antibiotics because somebody is afraid of the liability of

acknowledging all this increase in so called " asthma " is caused by mold

exposure

from the manner in which our buildings have been constructed in the past 25

years.

Sharon